Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The oral anticoagulant drug phenindione binds to and inhibit...

Class:IdSummation:9035052
_displayNameThe oral anticoagulant drug phenindione binds to and inhibit...
_timestamp2018-01-17 12:32:36
created[InstanceEdit:9035046] Jassal, Bijay, 2018-01-17
literatureReference[LiteratureReference:9035055] Effect in man of a new indandione anticoagulant
[LiteratureReference:9035061] Characterization of the T-cell response in a patient with phenindione hypersensitivity
textThe oral anticoagulant drug phenindione binds to and inhibits VKORC1, acting in a similar way to warfarin (Field et al. 1952). However, phenindione can be associated with hypersensitivity reactions so is rarely used (Naisbitt et al. 2005).
(summation)[ChemicalDrug:9035044] phenindione [cytosol]
[Change default viewing format]
No pathways have been reviewed or authored by The oral anticoagulant drug phenindione binds to and inhibit... (9035052)